Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
191
-
Total shares
-
11.7M
-
Shares change
-
-2.55M
-
Total reported value, excl. options
-
$1.45B
-
Value change
-
-$404M
-
Put/Call ratio
-
0.42
-
Number of buys
-
91
-
Number of sells
-
-97
-
Price
-
$124.20
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2018
193 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q4 2018.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
.
Largest 10 shareholders include FIRST TRUST ADVISORS LP (4.1M shares), MORGAN STANLEY (1.55M shares), WELLS FARGO & COMPANY/MN (1.06M shares), BANK OF AMERICA CORP /DE/ (898K shares), UBS Group AG (588K shares), RAYMOND JAMES & ASSOCIATES (305K shares), Raymond James Financial Services Advisors, Inc. (258K shares), ROYAL BANK OF CANADA (245K shares), AMERIPRISE FINANCIAL INC (194K shares), and LPL Financial LLC (180K shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.